ProfileGDS5678 / 1449848_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 39% 40% 39% 42% 40% 37% 37% 41% 40% 40% 45% 47% 39% 39% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9210839
GSM967853U87-EV human glioblastoma xenograft - Control 22.9165140
GSM967854U87-EV human glioblastoma xenograft - Control 32.899239
GSM967855U87-EV human glioblastoma xenograft - Control 42.9256242
GSM967856U87-EV human glioblastoma xenograft - Control 52.8775640
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9327937
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9139937
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9426341
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8929140
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9140940
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0492845
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0780247
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.890239
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8972239